ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Condition : Alphabetically : S : Sexually Transmitted Diseases, Viral


Include trials that are no longer recruiting patients.

217 studies were found. Here are studies 1 to 50.
1.RecruitingAndrogen Effects in HIV-infected Women
Conditions: HIV Infection; HIV Wasting Syndrome
2.Not yet recruitingEvaluating Switching HIV Subject's Current Protease Inhibitor Therapies For A Fosamprenavir Therapy, Over 48 Weeks
Condition: HIV Infections
3.Not yet recruitingShort-Term Study Of A Once-Daily Fixed-Dose Combination Tablet In Antiretroviral-Naive HIV-1 Infected Subjects.
Condition: HIV Infections
4.Not yet recruitingHIV Assessment in Fuyang, Anhui Province, China
Condition: HIV Infections
5.Not yet recruitingEffectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings
Conditions: HIV Infections; Tuberculosis
6.RecruitingSafety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects
Condition: HIV Infection
7.RecruitingSafety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents
Conditions: HIV Infections; Influenza
8.Not yet recruitingSafety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052
Condition: HIV Infections
9.Not yet recruitingNine Month Course of Anti-HIV Medications for People Recently Infected with HIV
Condition: HIV Infections
10.RecruitingYoga for Treating People at Risk for Diabetes or With Both HIV and Depression
Conditions: HIV Infections; Diabetes; Depression
11.RecruitingAn Investigational Vaccine in Reducing the Incidence of Anogenital Warts in Young Men
Condition: Condylomata Acuminata
12.RecruitingMonotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-experienced HIV1 Infected Adults
Condition: HIV Infections
13.RecruitingTNX-355 with Optimized Background Therapy (OBT) in Treatment-Experienced Subjects with HIV-1
Condition: HIV Infections
14.Recruiting48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Condition: HIV Infections
15.Not yet recruitingOptimal Treatment for Kidney Disease in HIV Infected Adults
Conditions: HIV Infections; Kidney Disease
16.Not yet recruitingNNRTI- Versus PI-Containing Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child Transmission of HIV
Condition: HIV Infections
17.RecruitingA phase II open-label, randomized, active-controlled study comparing the efficacy and safety of once daily Fuzeon (enfuvirtide) dosing versus the currently recommended twice daily dosing in HIV-1 infected treatment experienced patients.
Condition: HIV Disease
18.Not yet recruitingSafety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients
Condition: HIV Infections
19.RecruitingEffect of Tenofovir DF on Bone Metabolism in Children
Condition: HIV Infections
20.RecruitingBlood Levels of Abacavir in HIV Infected Adolescents
Condition: HIV Infections
21.Not yet recruitingThree Month Course of Anti-HIV Medications for People Recently Infected with HIV
Condition: HIV Infections
22.RecruitingLong-term Follow-up of HIV Infected Patients Identified During Early Infection
Condition: HIV Infections
23.RecruitingComparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV
Condition: HIV Infections
24.RecruitingHIV Study Of GW433908 Versus Kaletra, Both With Abacavir/lamivudine In Therapy-Naive Patients
Condition: HIV Infections
25.RecruitingPeginterferon alpha-2a and ribavirin to treat hepatitis C in HIV-infected patients
Conditions: Hepatitis C; HIV Infections
26.RecruitingStudy of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy
Conditions: HIV Infections; Peripheral Nervous System Diseases; Pain
27.RecruitingSafety of and Immune Response to Cyclosporine A in Combination with Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults with Acute HIV Infection
Condition: HIV Infections
28.Not yet recruitingOnce-Daily PI/NNRTI Therapy Combinations for Treatment Naive, HIV Infected Patients in Resource-limited Conditions
Condition: HIV Infections
29.RecruitingSafety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV
Condition: HIV Infections
30.Not yet recruitingVoluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission
Condition: HIV Infections
31.Not yet recruitingAnti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV
Condition: HIV Infections
32.RecruitingAtazanavir/Ritonavir Maintenance Therapy
Condition: HIV Infections
33.Not yet recruitingSafety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults
Condition: HIV Infections
34.RecruitingSafety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers
Conditions: Healthy; HIV Infections
35.RecruitingTreatment of Abnormal Adipose Tissue Accumulation in HIV Patients
Conditions: HIV Infections; Lipodystrophy
36.RecruitingSafety and Effectiveness of the Oral HIV Entry Inhibitor SCH 417690 in HIV Infected Patients
Condition: HIV Infections
37.RecruitingA Clinical Research Study Of FDA-Approved HIV Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy
Condition: HIV Infections
38.RecruitingRoll-over Trial Only for HIV-1 Infected Subjects in Selected TMC114 Trials who Fail Treatment
Condition: HIV Infections
39.Not yet recruitingStrategies for Delivering Anti-HIV Therapy in South Africa
Condition: HIV Infections
40.RecruitingDaclizumab to Treat HIV-Infected Patients
Condition: HIV Infections
41.Not yet recruitingDaily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers with HIV
Conditions: HIV Infections; Tuberculosis; Pneumocystis carinii Pneumonia
42.RecruitingEffectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients
Condition: HIV Infections
43.RecruitingL-Carnitine to Treat Fatigue in AIDS Patients
Conditions: HIV Infections; AIDS
44.RecruitingComparing the Effects of Smoked and Oral Marijuana in Individuals with HIV/AIDS
Condition: HIV Infections
45.RecruitingSteps to Maximize Adherence to Anti-Retroviral Treatment (SMAART)
Condition: HIV Infections
46.Not yet recruitingSafety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People
Condition: HIV Infections
47.RecruitingPegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
Conditions: HIV Infections; Hepatitis C; Liver Disease
48.RecruitingAnti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis
Conditions: HIV Infections; Tuberculosis
49.Not yet recruitingDaily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia
Conditions: HIV Infections; HIV Seronegativity
50.RecruitingTipranavir in Combination with Ritonavir in HIV-Infected Children
Condition: HIV Infections

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act